Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions
SEC Form 4 Filing
Director Steve Krognes reported the vesting of restricted stock units into common stock of Guardant Health, Inc. on February 29, 2024.
Summary
- On February 29, 2024, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- 154 shares of common stock were acquired as a result of the vesting of restricted stock units.
- The price per share for the transaction was $0.
- Following the transaction, Krognes directly owns 3,085 shares of common stock and 4,320 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine transaction. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to investors regarding the holdings and transactions of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 08/09/2022 | Date of grant for the restricted stock unit award. |
| 06/30/2023 | Date when 25% of the restricted stock units vested. |
| 02/29/2024 | Date of the reported transaction where restricted stock units vested into common stock. |
| 03/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.